The capacity of inflammatory cells to adhere is critical to inflammato
ry responses and involves an array of adhesion molecules grouped into
distinct families, Intercellular adhesion molecule (ICAM)-1 has recent
ly attracted much interest in view of increasing evidence that it play
s a prominent role in allergic diseases such as asthma and rhinitis, A
part from its role in adhesion of inflammatory cells to vascular endot
helium, the extracellular matrix and epithelium, ICAM-1 mediates T-cel
l/T-cell, T-cell/target cell and T-cell/B-cell interactions, ICAM-1 on
the surface of T-cells is thought to participate in signal transducti
on and may thus modulate several functions including activation, proli
feration, cytotoxicity and cytokine production. Because ICAM-1 is the
receptor for the major group of rhinoviruses, the most important cause
of acute asthma attacks, binding of rhinovirus (RV) to ICAM-1 on T-ce
lls may, at least theoretically, modulate their function. We review he
re the role of ICAM-1 in asthma and focus more specifically on its exp
ression on T-cells, We present evidence for a general increase in ICAM
-1 expression in this disease including recent observations of enhance
d expression on the surface of T-cells in the airways lumen. Whilst th
e implications of intercellular adhesion molecule-1 upregulation in as
thma remain to be fully elucidated, its participation in cell traffick
ing and activation are being considered as a target for treatment. We
present here early attempts to interfere with intercellular adhesion m
olecule-1 as an adhesion molecule involved in cell influx and studies
aimed preventing virus-induced exacerbations of asthma in children bas
ed on the knowledge that intercellular adhesion molecule-1 is the rece
ptor for rhinoviruses.